Description
Semax research peptide
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) based on the ACTH(4-10) fragment, with a Pro-Gly-Pro extension that improves stability. It was developed in Russia and is studied in neuroscience research.
Product details
| Compound | Semax |
|---|---|
| Class | ACTH(4-10)-derived heptapeptide |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What research has examined
- Neurotrophic signalling: BDNF expression in rodent brain models.
- Cerebral ischaemia models: experimental stroke research.
- Peptide stability: the protective effect of the C-terminal PGP sequence.
Research interest does not establish a proven effect in humans.
Regulatory status
Semax is registered as a medicine in Russia but is not approved by the FDA or EMA. The material sold here is a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.